“There’s lots you can do even before the clinical trial starts to be more inclusive of the LGBTQ+ population.”
Sponsors who turn to the same study sites over and over again are missing out on others with sturdy local roots in underserved communities, expert says.
When the hopes raised by participation in clinical trials threaten to be dashed by economic and logistical realities, one foundation has been a “godsend” for many cancer patients.
Clinical trial teams need to understand that not all solutions are “one size fits all” and how to implement a “fit for purpose” model for each study, expert says.
“We can provide patients who have traditionally been left out of the clinical trial process with an opportunity to participate or learn more.”
